CIN : U24233KL2007SGC021616
Visitors : 1324834
0471-2945600/46




Notices

Essential Drugs Division

E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation

Essential Drugs Division

e-tender for the procurement of drugs/supplies for the year 2024-25 - Technical bid evaluation -Defects noticed/status- Published

Essential Drugs Division

KMSCL- e- tender for the Procurement of Drugs for the year 2024- 25- Price Bid Evaluation - Items Deferred - Final Bid Status - Published- reg

Essential Drugs Division

KMSCL- E-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid EValuation- items Deferred - Final Bid Status- Published- reg

Essential Drugs Division

KMSCL-E-tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation- Final Bid Status- Published- reg

Essential Drugs Division

KMSCL – E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Technical Bid Evaluation – Defects noticed and status

Essential Drugs Division

KMSCL – E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25 – Technical Bid Evaluation – Defects noticed and status

Essential Drugs Division

Defects noticed/status of the tender for the Procurement of Vitamin A Paediatric Oral Solution IP for the year 2023-24

Essential Drugs Division

e -tender for the Procurement of Drugs for the year 2024-25- Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status- Publised- reg

Essential Drugs Division

E-tender for the Procurement of Specialty Drugs for the year 2024-25 – Price Bid Evaluation – Final Bid Status– Published

Essential Drugs Division

Notice on Provisional Bid Status of Salt Testing Kit for the year 2023-24

Essential Drugs Division

e-tender for the procurement of veterinary drugs for the year 2023-24 - Annexures - Word Format- published

Essential Drugs Division

e-ender for the procurement of ANTI RETROVIRAL DRUGS FOR KSACS for the year 2024-25

Essential Drugs Division

KMSCL – E-tender for the Procurement of Drugs for the year 2024-25 – Notice - Technical Bid Evaluation - List of selected/rejected bidders/products for price bid evaluation – Published

Essential Drugs Division

KMSCL – E-tender for the Procurement of Specialty Drugs for the year 2024-25 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published

Essential Drugs Division

Re-tender for the Procurement of RECOMBINANT ANTI HAEMOPHILIC FACTOR VIII 250 IU & 500 IU for the year 2023-24

Essential Drugs Division

e-tender for the Procurement of Veterinary Medicines to the Animal Husbandry Department for the year 2023-24

Essential Drugs Division

List of selected/ rejected bidder for price bid evaluation-videe- tender No- KMSCL/ED/RC /STK/2023/013 dtd. 10-08-2023

Essential Drugs Division

e- tender for the Procurement of BIOLARVICIDE: BACILLUS THURINGIENSIS ISRAELIENSIS (BTI) FOR NVBDCP for the year 2023-2024

Essential Drugs Division

e-tender for the procurement& Supply of VITAMIN A ORAL SOLUTION IP for the year 2023-24.

Essential Drugs Division

Provisional Bid ranking status of Re-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2022-23 vide e-tender No- KMSCL/ED/INS-NVBDCP & PLAN/RC/2023/012 Dated 26.07.2023

Essential Drugs Division

e-tender for the procurement of drugs for the year 2024-25 - Notice on Technical Bid evaluation- Defects noticed/status - Amendment - Published

Essential Drugs Division

KMSCL- e -tender for the Procurement of Drugs for the year 2024-25- Tehnical Bid Evaluation - defects noticed/status- Published- reg

Essential Drugs Division

e- tender for the procurement of Speciality Drugs for the year 2024-25- Technical Bid Evaluation - Defects noticed and status - Published -reg

Essential Drugs Division

KMSCL- E- tender for the procurement of Recombinant Anti Haemophilic Factor VIII 1000 IU & 1500 IU for the year 2023-24 - Status of Technical Bid Evaluation - List of selected/ rejected bidder/ products for price bid evaluation- Published- reg

Essential Drugs Division

Notice on defects noted for rectification -Published-e-tender for the Procurement of Salt Testing Kit for the year 2023-24

Essential Drugs Division

Release of online EMD Essential Drugs - 2023-24 (EMD-ED-2023-24)

Essential Drugs Division

Release of Security Deposit - Tender for Animal Husbandary Medicine - 2021-22 (Sd-AHD-2021-22)

Essential Drugs Division

E-tender for the Procurement of Anti Haemophilia Drugs for the year 2023-24 - Price bid evaluation - Final Bid Status - Published

Essential Drugs Division

e-tender for the Procurement of Recombinant Anti Haemophilic Factor VIII 1000 IU & 1500 IU for the year 2023-24 -Technical Bid Evaluation - defects noticed/status - Published

Essential Drugs Division

Notice on Final Bid ranking status of Re-Tender for the Procurement of 3 HP Drugs for LTBI for the year 2023-24

Essential Drugs Division

E-tender for the Procurement of Anti Haemophilia Drugs for the year 2023-24 -Price Bid Evaluation - Suppliers Wise rate Quoted and Provisional Bid Status -Published

Essential Drugs Division

E-tender for the Procurement of Anti Cancer Drugs for the year 2024-25- Tender time extension- Amendment notice published

Essential Drugs Division

E-tender for the procurement of Anti Haemophilia Drugs for the year 2023-24 -Technical Bid Evaluation – List of selected/ rejected bidders/ products for price bid evaluation– Notice Published – reg.

Essential Drugs Division

Notice on Provisional Bid ranking status Published for Re-Tender for the Procurement of 3 HP Drugs for LTBI for the year 2023-24

Essential Drugs Division

List of selected/ rejected bidders/products for price bid evaluation vide tender No- Re-tender No. KMSCL/ED/INS-NVBDCP & PLAN/RC/2023/012

Essential Drugs Division

List of selected/ rejected bidder for price bid evaluation -Published against render for the Procurement of 3 HP Drugs for LTBI for the year 2023-24

Essential Drugs Division

e-tender for the procurement of drugs for the year 2024-25 "vide e-tender No. KMSCL/ED/I&II/RC/2022/020 dated 23.12.2023, and "e-tender for the procurement of Specialty drugs for the year 2024-25

Essential Drugs Division

e-tender for the Procurement of drugs & supplies for the year 2024-25

Essential Drugs Division

e-tender for the Procurement of Anti Cancer drugs for the year 2024-25"

Essential Drugs Division

e-tender for the Procurement of Anti Cancer drugs for the year 2024-25"

Essential Drugs Division

e-tender for the Procurement of Anti Cancer drugs for the year 2024-25"

Essential Drugs Division

Essential Drugs Procurement division Of KMSCL List Of Blacklisted Firms

Essential Drugs Division

e-tender for the procurement of Drugs for the year 2024-25- ANNEXURES- WORD FORMAT

Essential Drugs Division

e-tender for the procurement of Drugs/Supplies for the year 2024-25- ANNEXURES- WORD FORMAT

Essential Drugs Division

e-tender for the procurement of Specialty Drugs for the year 2024-25- ANNEXURES- WORD FORMAT

Essential Drugs Division

Expert committee meeting on Complaints/representations received against the notice on Technical Bid evaluation –Notice on defects noted for rectification against tender for procurement & supply of 3 HP Drugs for LTBI

Essential Drugs Division

KMSCL – E-tender for the Procurement of Drugs for Rare Diseases for SATH under NPRD for the year 2023-24 – Technical Bid Evaluation – Defects noticed/status– Published

Essential Drugs Division

Notice on defects noted for rectification of Complaints/representations received against the notice on Technical Bid evaluation published–Expert committee meeting

Essential Drugs Division

E-tender for the procurement of drugs for Rare Diseases for the year 2023-24 – Time Extension Notice – published

Essential Drugs Division

e-tender for the procurement of Recombinant Anti Haemophilic Factors for the year 2023-24 - Time Extension Notice - Published

Essential Drugs Division

e-tender for the procurement of drugs for Rare Disease for the year 2023-24

Essential Drugs Division

LIST OF ITEMS NOT HAVING ELIGIBLE BIDDERS AGAINST THE E-TENDERS FOR THE YEAR 2023-24

Essential Drugs Division

ë-tender for the Procurement of Recombinant AntiHaemophilic Factor VIII 1000IU and 1500IU for the year 2023-24 vide E-tender No. KMSCL/ED/HAEM/2023/018 dated 15.11.2023

Essential Drugs Division

ë-tender for the Procurement of Recombinant AntiHaemophilic Factor VIII 250IU and 500IU for the year 2023-24 vide E-tender No. KMSCL/ED/HAEM/2023/017 dated 15.11.2023

Essential Drugs Division

E-tender for the Procurement of Anti Cancer Drugs for the year 2023-24 - Price Bid Evaluation - Notice on Provisional Bid Ranking Status- for Rock Bottom Price Published

Essential Drugs Division

e-tender for the procurement of 3HP Drugs for LTBI for the year 2023-24 - Time Extension Notice Published